Patrick J. Lord
About Patrick J. Lord
Patrick J. Lord, Ph.D., is Executive Vice President and Chief Operating Officer (COO) of Lam Research, a role he has held since March 1, 2023; he is 59 years old as of August 2025 and holds B.S., M.S., and Ph.D. degrees in mechanical engineering from MIT . His remit spans Global Operations; Customer Support; Global Quality; Environmental Health & Safety; Global Government Affairs & Trade; Information Technology; Cybersecurity; and Global Resilience, Security & Transformation, reflecting broad operational accountability and risk management oversight . Under his tenure, Lam’s calendar-year 2024 revenue was approximately $16.2B (+13% y/y), with operating cash flow of ~$4.6B (28% of revenues), while FY2025 reported net income of ~$340M and non-GAAP operating margin of 32.3%, aligning his incentive metrics to profitability and TSR outcomes .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Lam Research | EVP & COO | Mar 2023–present | Expanded remit to include GIS and Global Resilience/Security/Transformation; drive operational effectiveness, productivity, and business resilience . |
| Lam Research | EVP, CSBG & Global Operations | Sep 2020–Feb 2023 | Led Customer Support Business Group and global operations, integrating lifecycle support with cost/quality initiatives . |
| Lam Research | SVP & GM, CSBG | Dec 2016–Sep 2020 | Scaled CSBG revenues and offerings across spares, refurbishment and upgrades to optimize uptime and cost for customers . |
| Lam Research | Group VP & Deputy GM, Global Products Group | Sep 2013–Dec 2016 | Product design/engineering governance across etch/deposition; business processes for cost, quality, volume, reliability . |
| Lam Research (via Novellus acquisition) | Head of DGSI Business Units | Jun 2012–Sep 2013 | Led Direct Metals, GapFill, Surface Integrity Group & Integrated Metals units following Novellus acquisition . |
| Novellus Systems | SVP & GM, DGSI; SVP BD & Strategic Planning | 2001–2012 | Business development, strategic planning, and BU leadership across CMP, DGSI; senior roles in marketing and product . |
| KLA-Tencor | Product marketing/management roles | ~1995–2001 | Product marketing and management across inspection/metrology, pre-Lam career foundation . |
External Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Novellus Systems | Various senior roles incl. SVP/GM, BD & Strategic Planning | 2001–2012 | Grew multiple process BUs and strategic planning capabilities prior to Lam acquisition . |
| KLA-Tencor | Product marketing/management | ~1995–2001 | Market-led product management experience in inspection/metrology . |
Fixed Compensation
| Metric | CY 2023 | CY 2024 | CY 2025 |
|---|---|---|---|
| Base Salary ($) | 577,661 | 685,000 | 725,000 |
| Target Bonus (% of Base) | 110% | 110% | 110% |
| Target Bonus ($) | 635,427 | 753,500 | 797,500 |
| Actual AIP Paid ($) | 610,010 | 922,510 | — |
Calendar 2024 AIP mechanics and payout (Dr. Lord)
| Component | Metric | Weighting | Target level design | Actual Result | Factor Applied |
|---|---|---|---|---|---|
| Funding Factor | non-GAAP operating margin | N/A | Sets max pool funding | 250.0% of target pool | 2.50x |
| Corporate Performance Factor | non-GAAP operating margin | 1/3 | Stretch goal above AOP; scaled more rapidly around AOP for 2024 | Achieved | 1.06 |
| Profitability Performance Factor | non-GAAP gross margin | 1/3 | Stretch goal above AOP; scaled more rapidly around AOP for 2024 | Achieved | 1.10 |
| Individual Performance Factor | Corporate & individual goals | 1/3 | Weighted corporate plan contribution, individual contribution, corporate modifier | Average for NEOs | 1.05 |
| Dr. Lord payout ($) | Computed | — | 2024 target $753,500 | Result | $922,510 |
Performance Compensation
LTIP structure and grants
| Program | Vehicle | Metric | Mix (% of LTIP target) | Grant/Performance Dates | Vesting | Grant Details (Dr. Lord) |
|---|---|---|---|---|---|---|
| 2025/2027 LTIP | Market-based PRSUs | Relative TSR vs XSOX (percentile rank); capped at 100% if absolute TSR negative | 60% (EVP) | Grant 2/28/2025; Performance 2/3/2025–2/2/2028 | Cliff at 3 years | 40,565 target PRSUs |
| 2025/2027 LTIP | Service-based RSUs | Service | 40% (EVP) | Grant 2/28/2025 | 1/3 vest on 1st, 2nd, 3rd anniversaries | 27,043 RSUs |
| 2022/2024 LTIP payout | Market-based PRSUs | TSR vs XSOX (index comparison) | — | Performance 2/1/2022–1/31/2025 | — | 56.94% of target; 17,309 shares paid |
Market-based PRSU payout curve (2025/2027)
| TSR Percentile vs XSOX | Earned (% of Target) |
|---|---|
| ≥75th percentile | 150% |
| 50th percentile | 100% |
| 25th percentile | 50% |
| <25th percentile | 0% |
Options and vesting schedules
| Grant Date | Exercisable (#) | Unexercisable (#) | Exercise Price | Vesting Convention |
|---|---|---|---|---|
| 3/1/2024 | 10,610 | 21,220 | $98.15 | 1/3 annually for 3 years |
| 3/1/2023 | 14,070 | 14,070 | $49.09 | 1/3 annually for 3 years |
| 3/1/2022 | 10,130 | — | $54.06 | Fully vested; original 3-year schedule |
Equity Ownership & Alignment
| Item | Value |
|---|---|
| Beneficial ownership (shares) | 71,455; <1% of class (outstanding shares 1,261,032,300) |
| Shares vest/exercisable within 60 days | 34,810 (options/RSUs) |
| Unvested RSUs (2/28/2025 grant) | 27,043; market value $2,628,580 at $97.20 closing price |
| Market-based PRSUs (target, 2/28/2025 grant) | 40,565; target payout value $3,942,918 at $97.20 |
| Stock ownership guideline (EVP) | 2× base salary; executive officers in compliance or have time remaining |
| Hedging/pledging | Prohibited under insider trading policy . |
Alignment notes
- LTIP is majority performance-based (relative TSR) with explicit negative-TSR cap, increasing sensitivity to shareholder outcomes .
- AIP uses profitability (non-GAAP operating margin and gross margin) plus corporate/individual goals, reinforcing focus on margin discipline .
Employment Terms
Executive Severance & Change-in-Control (CIC) Economics (Tier 1 – EVP)
| Scenario | Cash Severance | Short-term Incentive | Equity Treatment | Benefits/Other |
|---|---|---|---|---|
| Involuntary (not for cause), no CIC/Acquisition | 100% of base salary; 150% for CEO | 50% of Five-Year Average; plus pro-rata current-year incentive (corporate results; individual at target/peer-average) | Pro-rata vesting of performance RSUs (cash based on performance to date × stock price); pro-rata vesting of service RSUs/options granted ≥12 months prior | Medical continuation; confidentiality/non-compete; release; 6-month non-solicit . |
| Disability/Death | Pro-rata current-year incentive (corporate results; individual at target/peer-average) | N/A | Vesting of service RSUs/options; pro-rata performance RSUs based on performance to date | Medical continuation . |
| CIC or Acquisition (double trigger) | 150% of base; 150% of Five-Year Average; plus pro-rata Five-Year Average in year of termination (200% multiples for CEO) | As above | Service RSUs/options granted prior to CIC: vest at termination; Performance RSUs: cash award = pro-rata performance to CIC + pro-rata target to period end × stock price | Medical continuation; release; 6-month non-solicit . |
Potential Payments Illustration (as of 6/29/2025; Dr. Lord)
| Scenario | Total ($) |
|---|---|
| Involuntary – Not for Cause | 7,459,099 |
| CIC or Acquisition (Double Trigger) | 18,559,011 |
| Disability/Death | 17,720,425 |
Governance/Policy Provisions
- Clawback: SEC/Nasdaq-compliant policy (effective 2023), recoupment of incentive-based compensation upon restatement regardless of fault; supersedes prior policy .
- Tax gross-ups: No gross-ups for perquisites/CIC; relocation gross-ups may apply broadly (example shown for another NEO) .
- Option repricing: Prohibited without shareholder approval .
- Insider trading: Hedging/pledging prohibited; blackout periods in effect .
Performance Compensation – Detailed AIP Table (CY 2024)
| Metric | Weight | Targeting Approach | Actual vs Target | Payout Factor |
|---|---|---|---|---|
| non-GAAP operating margin (Corporate) | 33.3% | Stretch goals above AOP; accelerated scaling between AOP and “1.0” level (2024 only) | Achieved stretch | 1.06 |
| non-GAAP gross margin (Profitability) | 33.3% | Stretch goals above AOP; accelerated scaling between AOP and “1.0” level (2024 only) | Achieved stretch | 1.10 |
| Individual Performance | 33.3% | Corporate plan contribution + individual contributions + corporate modifier | Avg. applied to NEOs | 1.05 |
Compensation Structure Analysis
- Shift from options to RSUs: 2025/2027 LTIP removed options, increasing service RSU mix while keeping market-based PRSUs constant; committee cited resilience amid stock volatility and peer alignment .
- Negative TSR cap: PRSU payouts capped at 100% if absolute TSR is negative, limiting upside in down markets .
- AIP complexity reverted: 2025 AIP returns to linear factor relationships (removing 2024 accelerated scaling) to reduce complexity while maintaining stretch goals .
- Strong Say-on-Pay: Advisory approvals exceeded 90% from 2021–2024, signaling investor support for pay design .
Equity Ownership & Pledging
- Ownership guidelines: EVP 2× salary; all NEOs in compliance or within the allowed time window to reach compliance .
- Pledging/hedging: Prohibited by policy, reducing alignment risk; exchange fund participation limited and diversified .
- Related-party transactions: None reported for executives in FY2025, reducing conflict risk .
Expertise & Qualifications
- Technical/operator: Nearly three decades across semiconductor equipment operations and product leadership; prior senior roles at Novellus; product/marketing roles at KLA-Tencor; MIT-trained engineer .
- COO remit: Cross-functional leadership including cybersecurity and government affairs/trade, aligning with Lam’s risk and compliance scope .
- Appointment details: Named COO effective March 1, 2023; no special arrangements; no family relationships or related transactions .
Investment Implications
- High alignment: Majority performance-based LTIP tied to relative TSR with negative-TSR cap, AIP anchored to operating and gross margin, and strict hedging/pledging prohibitions support shareholder alignment .
- Realized performance signal: 2022/2024 PRSU payout of 56.94% (underperforming XSOX) indicates realistic calibration and payout discipline; near-term RSU vesting and options schedules provide predictable supply, with some options deeply in-the-money and others near current pricing .
- Retention economics: Double-trigger CIC and pro-rata vesting mechanics reduce windfall risk while providing retention; severance multiples for EVPs are moderate vs peers, with clawback overlay mitigating restatement risk .
- Business performance backdrop: CY2024 revenue growth (+13% y/y to ~$16.2B) and FY2025 non-GAAP margin (32.3%) tie directly to AIP profitability metrics, reinforcing management focus on margin and cash generation .
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Best AI for Equity Research
Performance on expert-authored financial analysis tasks